adi spa Search Results


90
Enzo Biochem bip antibody, adi-spa-818 d
Bip Antibody, Adi Spa 818 D, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bip antibody, adi-spa-818 d/product/Enzo Biochem
Average 90 stars, based on 1 article reviews
bip antibody, adi-spa-818 d - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Enzo Biochem phycoerythrin-conjugated crt monoclonal antibody (cat. no. adi-spa-601pe-d)
Phycoerythrin Conjugated Crt Monoclonal Antibody (Cat. No. Adi Spa 601pe D), supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phycoerythrin-conjugated crt monoclonal antibody (cat. no. adi-spa-601pe-d)/product/Enzo Biochem
Average 90 stars, based on 1 article reviews
phycoerythrin-conjugated crt monoclonal antibody (cat. no. adi-spa-601pe-d) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Assay Designs Inc pdi antibody spa-890
Association of TMX with <t>calnexin.</t> (A) Lysates (left) and anti-myc immunoprecipitates (right, IP: myc) from A549 cells stably transfected with control vector (V) or TMX-myc (TMX) were analyzed by immunoblotting (IB) <t>with</t> <t>antibodies</t> to calnexin (CNX), calreticulin (CRT), and myc. (B) 293 cells were subjected to immunoprecipitation with control (Ctrl) or anti-calnexin (CNX) antibody, and immunoblotted with antibodies to calnexin and TMX. (C) Top, schematic structure of TMX and its C-terminally truncated variants. SP, signal peptide; TRX domain, thioredoxin-like domain; TM, transmembrane domain. Bottom, 293 cells were transfected with different TMX-myc variants as indicated. Cell lysates (lanes 1–3) and anti-myc immunoprecipitates from the culture supernatants (lanes 4–6) were analyzed by immunoblotting with anti-myc antibody. (D) Left, TMX140-myc with (−) or without (+) ER-retention signal KDEL was transfected into 293 cells. The cells were fractionated into cytosolic (C) and membrane fractions (M), and the culture supernatants (S) were immunoprecipitated with anti-myc. The resulting samples were immunoblotted with anti-myc. Right, separation of cytosolic and membrane fractions was confirmed by immunoblotting with anti-thioredoxin (TRX, cytosolic marker) and anti-TMX (ER). (E) 293 cells transfected with control vector (V), TMX-myc (WT), TMX215-myc (215), TMX140-mycKDEL (140+), TMX/C56S·C59S-myc (CS), or TMX/C56A·C59A-myc (CA) were subjected to immunoprecipitation with anti-myc and immunoblotted with anti-CNX and anti-myc.
Pdi Antibody Spa 890, supplied by Assay Designs Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pdi antibody spa-890/product/Assay Designs Inc
Average 90 stars, based on 1 article reviews
pdi antibody spa-890 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Enzo Biochem adi-spa-600
Association of TMX with <t>calnexin.</t> (A) Lysates (left) and anti-myc immunoprecipitates (right, IP: myc) from A549 cells stably transfected with control vector (V) or TMX-myc (TMX) were analyzed by immunoblotting (IB) <t>with</t> <t>antibodies</t> to calnexin (CNX), calreticulin (CRT), and myc. (B) 293 cells were subjected to immunoprecipitation with control (Ctrl) or anti-calnexin (CNX) antibody, and immunoblotted with antibodies to calnexin and TMX. (C) Top, schematic structure of TMX and its C-terminally truncated variants. SP, signal peptide; TRX domain, thioredoxin-like domain; TM, transmembrane domain. Bottom, 293 cells were transfected with different TMX-myc variants as indicated. Cell lysates (lanes 1–3) and anti-myc immunoprecipitates from the culture supernatants (lanes 4–6) were analyzed by immunoblotting with anti-myc antibody. (D) Left, TMX140-myc with (−) or without (+) ER-retention signal KDEL was transfected into 293 cells. The cells were fractionated into cytosolic (C) and membrane fractions (M), and the culture supernatants (S) were immunoprecipitated with anti-myc. The resulting samples were immunoblotted with anti-myc. Right, separation of cytosolic and membrane fractions was confirmed by immunoblotting with anti-thioredoxin (TRX, cytosolic marker) and anti-TMX (ER). (E) 293 cells transfected with control vector (V), TMX-myc (WT), TMX215-myc (215), TMX140-mycKDEL (140+), TMX/C56S·C59S-myc (CS), or TMX/C56A·C59A-myc (CA) were subjected to immunoprecipitation with anti-myc and immunoblotted with anti-CNX and anti-myc.
Adi Spa 600, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/adi-spa-600/product/Enzo Biochem
Average 90 stars, based on 1 article reviews
adi-spa-600 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Enzo Biochem adi-spa-865-d
Association of TMX with <t>calnexin.</t> (A) Lysates (left) and anti-myc immunoprecipitates (right, IP: myc) from A549 cells stably transfected with control vector (V) or TMX-myc (TMX) were analyzed by immunoblotting (IB) <t>with</t> <t>antibodies</t> to calnexin (CNX), calreticulin (CRT), and myc. (B) 293 cells were subjected to immunoprecipitation with control (Ctrl) or anti-calnexin (CNX) antibody, and immunoblotted with antibodies to calnexin and TMX. (C) Top, schematic structure of TMX and its C-terminally truncated variants. SP, signal peptide; TRX domain, thioredoxin-like domain; TM, transmembrane domain. Bottom, 293 cells were transfected with different TMX-myc variants as indicated. Cell lysates (lanes 1–3) and anti-myc immunoprecipitates from the culture supernatants (lanes 4–6) were analyzed by immunoblotting with anti-myc antibody. (D) Left, TMX140-myc with (−) or without (+) ER-retention signal KDEL was transfected into 293 cells. The cells were fractionated into cytosolic (C) and membrane fractions (M), and the culture supernatants (S) were immunoprecipitated with anti-myc. The resulting samples were immunoblotted with anti-myc. Right, separation of cytosolic and membrane fractions was confirmed by immunoblotting with anti-thioredoxin (TRX, cytosolic marker) and anti-TMX (ER). (E) 293 cells transfected with control vector (V), TMX-myc (WT), TMX215-myc (215), TMX140-mycKDEL (140+), TMX/C56S·C59S-myc (CS), or TMX/C56A·C59A-myc (CA) were subjected to immunoprecipitation with anti-myc and immunoblotted with anti-CNX and anti-myc.
Adi Spa 865 D, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/adi-spa-865-d/product/Enzo Biochem
Average 90 stars, based on 1 article reviews
adi-spa-865-d - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Enzo Biochem pdi (spa-891)
Association of TMX with <t>calnexin.</t> (A) Lysates (left) and anti-myc immunoprecipitates (right, IP: myc) from A549 cells stably transfected with control vector (V) or TMX-myc (TMX) were analyzed by immunoblotting (IB) <t>with</t> <t>antibodies</t> to calnexin (CNX), calreticulin (CRT), and myc. (B) 293 cells were subjected to immunoprecipitation with control (Ctrl) or anti-calnexin (CNX) antibody, and immunoblotted with antibodies to calnexin and TMX. (C) Top, schematic structure of TMX and its C-terminally truncated variants. SP, signal peptide; TRX domain, thioredoxin-like domain; TM, transmembrane domain. Bottom, 293 cells were transfected with different TMX-myc variants as indicated. Cell lysates (lanes 1–3) and anti-myc immunoprecipitates from the culture supernatants (lanes 4–6) were analyzed by immunoblotting with anti-myc antibody. (D) Left, TMX140-myc with (−) or without (+) ER-retention signal KDEL was transfected into 293 cells. The cells were fractionated into cytosolic (C) and membrane fractions (M), and the culture supernatants (S) were immunoprecipitated with anti-myc. The resulting samples were immunoblotted with anti-myc. Right, separation of cytosolic and membrane fractions was confirmed by immunoblotting with anti-thioredoxin (TRX, cytosolic marker) and anti-TMX (ER). (E) 293 cells transfected with control vector (V), TMX-myc (WT), TMX215-myc (215), TMX140-mycKDEL (140+), TMX/C56S·C59S-myc (CS), or TMX/C56A·C59A-myc (CA) were subjected to immunoprecipitation with anti-myc and immunoblotted with anti-CNX and anti-myc.
Pdi (Spa 891), supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pdi (spa-891)/product/Enzo Biochem
Average 90 stars, based on 1 article reviews
pdi (spa-891) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Enzo Biochem rabbit anti-heat shock 70 protein antibodies (adi-spa-816; 1:5000)
Association of TMX with <t>calnexin.</t> (A) Lysates (left) and anti-myc immunoprecipitates (right, IP: myc) from A549 cells stably transfected with control vector (V) or TMX-myc (TMX) were analyzed by immunoblotting (IB) <t>with</t> <t>antibodies</t> to calnexin (CNX), calreticulin (CRT), and myc. (B) 293 cells were subjected to immunoprecipitation with control (Ctrl) or anti-calnexin (CNX) antibody, and immunoblotted with antibodies to calnexin and TMX. (C) Top, schematic structure of TMX and its C-terminally truncated variants. SP, signal peptide; TRX domain, thioredoxin-like domain; TM, transmembrane domain. Bottom, 293 cells were transfected with different TMX-myc variants as indicated. Cell lysates (lanes 1–3) and anti-myc immunoprecipitates from the culture supernatants (lanes 4–6) were analyzed by immunoblotting with anti-myc antibody. (D) Left, TMX140-myc with (−) or without (+) ER-retention signal KDEL was transfected into 293 cells. The cells were fractionated into cytosolic (C) and membrane fractions (M), and the culture supernatants (S) were immunoprecipitated with anti-myc. The resulting samples were immunoblotted with anti-myc. Right, separation of cytosolic and membrane fractions was confirmed by immunoblotting with anti-thioredoxin (TRX, cytosolic marker) and anti-TMX (ER). (E) 293 cells transfected with control vector (V), TMX-myc (WT), TMX215-myc (215), TMX140-mycKDEL (140+), TMX/C56S·C59S-myc (CS), or TMX/C56A·C59A-myc (CA) were subjected to immunoprecipitation with anti-myc and immunoblotted with anti-CNX and anti-myc.
Rabbit Anti Heat Shock 70 Protein Antibodies (Adi Spa 816; 1:5000), supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-heat shock 70 protein antibodies (adi-spa-816; 1:5000)/product/Enzo Biochem
Average 90 stars, based on 1 article reviews
rabbit anti-heat shock 70 protein antibodies (adi-spa-816; 1:5000) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Enzo Biochem anti-hsp90α spa840
Association of TMX with <t>calnexin.</t> (A) Lysates (left) and anti-myc immunoprecipitates (right, IP: myc) from A549 cells stably transfected with control vector (V) or TMX-myc (TMX) were analyzed by immunoblotting (IB) <t>with</t> <t>antibodies</t> to calnexin (CNX), calreticulin (CRT), and myc. (B) 293 cells were subjected to immunoprecipitation with control (Ctrl) or anti-calnexin (CNX) antibody, and immunoblotted with antibodies to calnexin and TMX. (C) Top, schematic structure of TMX and its C-terminally truncated variants. SP, signal peptide; TRX domain, thioredoxin-like domain; TM, transmembrane domain. Bottom, 293 cells were transfected with different TMX-myc variants as indicated. Cell lysates (lanes 1–3) and anti-myc immunoprecipitates from the culture supernatants (lanes 4–6) were analyzed by immunoblotting with anti-myc antibody. (D) Left, TMX140-myc with (−) or without (+) ER-retention signal KDEL was transfected into 293 cells. The cells were fractionated into cytosolic (C) and membrane fractions (M), and the culture supernatants (S) were immunoprecipitated with anti-myc. The resulting samples were immunoblotted with anti-myc. Right, separation of cytosolic and membrane fractions was confirmed by immunoblotting with anti-thioredoxin (TRX, cytosolic marker) and anti-TMX (ER). (E) 293 cells transfected with control vector (V), TMX-myc (WT), TMX215-myc (215), TMX140-mycKDEL (140+), TMX/C56S·C59S-myc (CS), or TMX/C56A·C59A-myc (CA) were subjected to immunoprecipitation with anti-myc and immunoblotted with anti-CNX and anti-myc.
Anti Hsp90α Spa840, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-hsp90α spa840/product/Enzo Biochem
Average 90 stars, based on 1 article reviews
anti-hsp90α spa840 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Enzo Biochem adi-spa-400
Association of TMX with <t>calnexin.</t> (A) Lysates (left) and anti-myc immunoprecipitates (right, IP: myc) from A549 cells stably transfected with control vector (V) or TMX-myc (TMX) were analyzed by immunoblotting (IB) <t>with</t> <t>antibodies</t> to calnexin (CNX), calreticulin (CRT), and myc. (B) 293 cells were subjected to immunoprecipitation with control (Ctrl) or anti-calnexin (CNX) antibody, and immunoblotted with antibodies to calnexin and TMX. (C) Top, schematic structure of TMX and its C-terminally truncated variants. SP, signal peptide; TRX domain, thioredoxin-like domain; TM, transmembrane domain. Bottom, 293 cells were transfected with different TMX-myc variants as indicated. Cell lysates (lanes 1–3) and anti-myc immunoprecipitates from the culture supernatants (lanes 4–6) were analyzed by immunoblotting with anti-myc antibody. (D) Left, TMX140-myc with (−) or without (+) ER-retention signal KDEL was transfected into 293 cells. The cells were fractionated into cytosolic (C) and membrane fractions (M), and the culture supernatants (S) were immunoprecipitated with anti-myc. The resulting samples were immunoblotted with anti-myc. Right, separation of cytosolic and membrane fractions was confirmed by immunoblotting with anti-thioredoxin (TRX, cytosolic marker) and anti-TMX (ER). (E) 293 cells transfected with control vector (V), TMX-myc (WT), TMX215-myc (215), TMX140-mycKDEL (140+), TMX/C56S·C59S-myc (CS), or TMX/C56A·C59A-myc (CA) were subjected to immunoprecipitation with anti-myc and immunoblotted with anti-CNX and anti-myc.
Adi Spa 400, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/adi-spa-400/product/Enzo Biochem
Average 90 stars, based on 1 article reviews
adi-spa-400 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Enzo Biochem hsp90α (hspc2
Association of TMX with <t>calnexin.</t> (A) Lysates (left) and anti-myc immunoprecipitates (right, IP: myc) from A549 cells stably transfected with control vector (V) or TMX-myc (TMX) were analyzed by immunoblotting (IB) <t>with</t> <t>antibodies</t> to calnexin (CNX), calreticulin (CRT), and myc. (B) 293 cells were subjected to immunoprecipitation with control (Ctrl) or anti-calnexin (CNX) antibody, and immunoblotted with antibodies to calnexin and TMX. (C) Top, schematic structure of TMX and its C-terminally truncated variants. SP, signal peptide; TRX domain, thioredoxin-like domain; TM, transmembrane domain. Bottom, 293 cells were transfected with different TMX-myc variants as indicated. Cell lysates (lanes 1–3) and anti-myc immunoprecipitates from the culture supernatants (lanes 4–6) were analyzed by immunoblotting with anti-myc antibody. (D) Left, TMX140-myc with (−) or without (+) ER-retention signal KDEL was transfected into 293 cells. The cells were fractionated into cytosolic (C) and membrane fractions (M), and the culture supernatants (S) were immunoprecipitated with anti-myc. The resulting samples were immunoblotted with anti-myc. Right, separation of cytosolic and membrane fractions was confirmed by immunoblotting with anti-thioredoxin (TRX, cytosolic marker) and anti-TMX (ER). (E) 293 cells transfected with control vector (V), TMX-myc (WT), TMX215-myc (215), TMX140-mycKDEL (140+), TMX/C56S·C59S-myc (CS), or TMX/C56A·C59A-myc (CA) were subjected to immunoprecipitation with anti-myc and immunoblotted with anti-CNX and anti-myc.
Hsp90α (Hspc2, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hsp90α (hspc2/product/Enzo Biochem
Average 90 stars, based on 1 article reviews
hsp90α (hspc2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Enzo Biochem adi-spa-757
Association of TMX with <t>calnexin.</t> (A) Lysates (left) and anti-myc immunoprecipitates (right, IP: myc) from A549 cells stably transfected with control vector (V) or TMX-myc (TMX) were analyzed by immunoblotting (IB) <t>with</t> <t>antibodies</t> to calnexin (CNX), calreticulin (CRT), and myc. (B) 293 cells were subjected to immunoprecipitation with control (Ctrl) or anti-calnexin (CNX) antibody, and immunoblotted with antibodies to calnexin and TMX. (C) Top, schematic structure of TMX and its C-terminally truncated variants. SP, signal peptide; TRX domain, thioredoxin-like domain; TM, transmembrane domain. Bottom, 293 cells were transfected with different TMX-myc variants as indicated. Cell lysates (lanes 1–3) and anti-myc immunoprecipitates from the culture supernatants (lanes 4–6) were analyzed by immunoblotting with anti-myc antibody. (D) Left, TMX140-myc with (−) or without (+) ER-retention signal KDEL was transfected into 293 cells. The cells were fractionated into cytosolic (C) and membrane fractions (M), and the culture supernatants (S) were immunoprecipitated with anti-myc. The resulting samples were immunoblotted with anti-myc. Right, separation of cytosolic and membrane fractions was confirmed by immunoblotting with anti-thioredoxin (TRX, cytosolic marker) and anti-TMX (ER). (E) 293 cells transfected with control vector (V), TMX-myc (WT), TMX215-myc (215), TMX140-mycKDEL (140+), TMX/C56S·C59S-myc (CS), or TMX/C56A·C59A-myc (CA) were subjected to immunoprecipitation with anti-myc and immunoblotted with anti-CNX and anti-myc.
Adi Spa 757, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/adi-spa-757/product/Enzo Biochem
Average 90 stars, based on 1 article reviews
adi-spa-757 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Enzo Biochem hsp70b monoclonal antibody (mouse
Association of TMX with <t>calnexin.</t> (A) Lysates (left) and anti-myc immunoprecipitates (right, IP: myc) from A549 cells stably transfected with control vector (V) or TMX-myc (TMX) were analyzed by immunoblotting (IB) <t>with</t> <t>antibodies</t> to calnexin (CNX), calreticulin (CRT), and myc. (B) 293 cells were subjected to immunoprecipitation with control (Ctrl) or anti-calnexin (CNX) antibody, and immunoblotted with antibodies to calnexin and TMX. (C) Top, schematic structure of TMX and its C-terminally truncated variants. SP, signal peptide; TRX domain, thioredoxin-like domain; TM, transmembrane domain. Bottom, 293 cells were transfected with different TMX-myc variants as indicated. Cell lysates (lanes 1–3) and anti-myc immunoprecipitates from the culture supernatants (lanes 4–6) were analyzed by immunoblotting with anti-myc antibody. (D) Left, TMX140-myc with (−) or without (+) ER-retention signal KDEL was transfected into 293 cells. The cells were fractionated into cytosolic (C) and membrane fractions (M), and the culture supernatants (S) were immunoprecipitated with anti-myc. The resulting samples were immunoblotted with anti-myc. Right, separation of cytosolic and membrane fractions was confirmed by immunoblotting with anti-thioredoxin (TRX, cytosolic marker) and anti-TMX (ER). (E) 293 cells transfected with control vector (V), TMX-myc (WT), TMX215-myc (215), TMX140-mycKDEL (140+), TMX/C56S·C59S-myc (CS), or TMX/C56A·C59A-myc (CA) were subjected to immunoprecipitation with anti-myc and immunoblotted with anti-CNX and anti-myc.
Hsp70b Monoclonal Antibody (Mouse, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hsp70b monoclonal antibody (mouse/product/Enzo Biochem
Average 90 stars, based on 1 article reviews
hsp70b monoclonal antibody (mouse - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Association of TMX with calnexin. (A) Lysates (left) and anti-myc immunoprecipitates (right, IP: myc) from A549 cells stably transfected with control vector (V) or TMX-myc (TMX) were analyzed by immunoblotting (IB) with antibodies to calnexin (CNX), calreticulin (CRT), and myc. (B) 293 cells were subjected to immunoprecipitation with control (Ctrl) or anti-calnexin (CNX) antibody, and immunoblotted with antibodies to calnexin and TMX. (C) Top, schematic structure of TMX and its C-terminally truncated variants. SP, signal peptide; TRX domain, thioredoxin-like domain; TM, transmembrane domain. Bottom, 293 cells were transfected with different TMX-myc variants as indicated. Cell lysates (lanes 1–3) and anti-myc immunoprecipitates from the culture supernatants (lanes 4–6) were analyzed by immunoblotting with anti-myc antibody. (D) Left, TMX140-myc with (−) or without (+) ER-retention signal KDEL was transfected into 293 cells. The cells were fractionated into cytosolic (C) and membrane fractions (M), and the culture supernatants (S) were immunoprecipitated with anti-myc. The resulting samples were immunoblotted with anti-myc. Right, separation of cytosolic and membrane fractions was confirmed by immunoblotting with anti-thioredoxin (TRX, cytosolic marker) and anti-TMX (ER). (E) 293 cells transfected with control vector (V), TMX-myc (WT), TMX215-myc (215), TMX140-mycKDEL (140+), TMX/C56S·C59S-myc (CS), or TMX/C56A·C59A-myc (CA) were subjected to immunoprecipitation with anti-myc and immunoblotted with anti-CNX and anti-myc.

Journal: Molecular Biology of the Cell

Article Title: Physical and Functional Interaction of Transmembrane Thioredoxin-related Protein with Major Histocompatibility Complex Class I Heavy Chain: Redox-based Protein Quality Control and Its Potential Relevance to Immune Responses

doi: 10.1091/mbc.E09-05-0439

Figure Lengend Snippet: Association of TMX with calnexin. (A) Lysates (left) and anti-myc immunoprecipitates (right, IP: myc) from A549 cells stably transfected with control vector (V) or TMX-myc (TMX) were analyzed by immunoblotting (IB) with antibodies to calnexin (CNX), calreticulin (CRT), and myc. (B) 293 cells were subjected to immunoprecipitation with control (Ctrl) or anti-calnexin (CNX) antibody, and immunoblotted with antibodies to calnexin and TMX. (C) Top, schematic structure of TMX and its C-terminally truncated variants. SP, signal peptide; TRX domain, thioredoxin-like domain; TM, transmembrane domain. Bottom, 293 cells were transfected with different TMX-myc variants as indicated. Cell lysates (lanes 1–3) and anti-myc immunoprecipitates from the culture supernatants (lanes 4–6) were analyzed by immunoblotting with anti-myc antibody. (D) Left, TMX140-myc with (−) or without (+) ER-retention signal KDEL was transfected into 293 cells. The cells were fractionated into cytosolic (C) and membrane fractions (M), and the culture supernatants (S) were immunoprecipitated with anti-myc. The resulting samples were immunoblotted with anti-myc. Right, separation of cytosolic and membrane fractions was confirmed by immunoblotting with anti-thioredoxin (TRX, cytosolic marker) and anti-TMX (ER). (E) 293 cells transfected with control vector (V), TMX-myc (WT), TMX215-myc (215), TMX140-mycKDEL (140+), TMX/C56S·C59S-myc (CS), or TMX/C56A·C59A-myc (CA) were subjected to immunoprecipitation with anti-myc and immunoblotted with anti-CNX and anti-myc.

Article Snippet: Rabbit polyclonal antibodies specific for calreticulin (SPA-600), calnexin (SPA-865), and PDI (SPA-890) were from Assay Designs (Ann Arbor, MI).

Techniques: Stable Transfection, Transfection, Control, Plasmid Preparation, Western Blot, Immunoprecipitation, Membrane, Marker

Trapping mutants of TMX. (A) Lysates from 293 cells transfected with the indicated TMX-myc variants were separated under nonreducing (lanes 1–3) or reducing conditions (lanes 4–6) and immunoblotted with anti-myc. (B) top, 293 cells harboring the tetracycline-inducible TMX transgene (293:tet-TMX/P101T-myc) were treated with doxycycline (dox; 0–0.8 μg/ml) for 24 h. The expression of endogenous TMX and TMX/P101T-myc was examined by immunoblotting with anti-TMX antibody. Bottom, 293:tet-TMX/P101T-myc was treated with castanospermine (CST; 0, 0.5, and 1.0 mM) for 8 h and further incubated in the presence of dox (0.4 μg/ml) for 15 h. The formation of mixed disulfides was analyzed as described in A. (C) 293 cells were transfected with control vector, TMX/P101T-myc (P101T), or TMX/C56A·C59A-myc (C56·59A), and the lysates were immunoprecipitated with anti-calnexin (CNX) antibody. The immunoprecipitates were assessed for the presence of TMX-substrate complexes by immunoblotting with anti-myc. A putative TMX dimer is indicated by an asterisk.

Journal: Molecular Biology of the Cell

Article Title: Physical and Functional Interaction of Transmembrane Thioredoxin-related Protein with Major Histocompatibility Complex Class I Heavy Chain: Redox-based Protein Quality Control and Its Potential Relevance to Immune Responses

doi: 10.1091/mbc.E09-05-0439

Figure Lengend Snippet: Trapping mutants of TMX. (A) Lysates from 293 cells transfected with the indicated TMX-myc variants were separated under nonreducing (lanes 1–3) or reducing conditions (lanes 4–6) and immunoblotted with anti-myc. (B) top, 293 cells harboring the tetracycline-inducible TMX transgene (293:tet-TMX/P101T-myc) were treated with doxycycline (dox; 0–0.8 μg/ml) for 24 h. The expression of endogenous TMX and TMX/P101T-myc was examined by immunoblotting with anti-TMX antibody. Bottom, 293:tet-TMX/P101T-myc was treated with castanospermine (CST; 0, 0.5, and 1.0 mM) for 8 h and further incubated in the presence of dox (0.4 μg/ml) for 15 h. The formation of mixed disulfides was analyzed as described in A. (C) 293 cells were transfected with control vector, TMX/P101T-myc (P101T), or TMX/C56A·C59A-myc (C56·59A), and the lysates were immunoprecipitated with anti-calnexin (CNX) antibody. The immunoprecipitates were assessed for the presence of TMX-substrate complexes by immunoblotting with anti-myc. A putative TMX dimer is indicated by an asterisk.

Article Snippet: Rabbit polyclonal antibodies specific for calreticulin (SPA-600), calnexin (SPA-865), and PDI (SPA-890) were from Assay Designs (Ann Arbor, MI).

Techniques: Transfection, Expressing, Western Blot, Incubation, Control, Plasmid Preparation, Immunoprecipitation

TMX forms a disulfide-linked complex with MHC class I heavy chain. (A) 293 cells transfected with control vector or the indicated TMX-myc variants were subjected to immunoprecipitation with anti-myc. Cell lysates and the immunoprecipitates were analyzed by immunoblotting with anti-class I HC and anti-myc. Monomeric class I HC (open arrowhead) and the TMX-class I HC conjugate (closed arrowhead) are indicated (top). Red, reducing; Nonred, nonreducing. (B) Anti-myc immunoprecipitates from 293 cells transfected with TMX/C59A-myc were separated on a nonreducing/reducing two-dimensional gel, and analyzed by immunoblotting with antibodies to calnexin (CNX), class I HC, and myc. Calnexin was visible on the gel diagonal between the two arrows (circled). The arrowhead indicates MHC class I HC originated from the disulfide-linked complex.

Journal: Molecular Biology of the Cell

Article Title: Physical and Functional Interaction of Transmembrane Thioredoxin-related Protein with Major Histocompatibility Complex Class I Heavy Chain: Redox-based Protein Quality Control and Its Potential Relevance to Immune Responses

doi: 10.1091/mbc.E09-05-0439

Figure Lengend Snippet: TMX forms a disulfide-linked complex with MHC class I heavy chain. (A) 293 cells transfected with control vector or the indicated TMX-myc variants were subjected to immunoprecipitation with anti-myc. Cell lysates and the immunoprecipitates were analyzed by immunoblotting with anti-class I HC and anti-myc. Monomeric class I HC (open arrowhead) and the TMX-class I HC conjugate (closed arrowhead) are indicated (top). Red, reducing; Nonred, nonreducing. (B) Anti-myc immunoprecipitates from 293 cells transfected with TMX/C59A-myc were separated on a nonreducing/reducing two-dimensional gel, and analyzed by immunoblotting with antibodies to calnexin (CNX), class I HC, and myc. Calnexin was visible on the gel diagonal between the two arrows (circled). The arrowhead indicates MHC class I HC originated from the disulfide-linked complex.

Article Snippet: Rabbit polyclonal antibodies specific for calreticulin (SPA-600), calnexin (SPA-865), and PDI (SPA-890) were from Assay Designs (Ann Arbor, MI).

Techniques: Transfection, Control, Plasmid Preparation, Immunoprecipitation, Western Blot, Two-Dimensional Gel Electrophoresis

Role of TMX in the degradation of MHC class I heavy chain. (A) A549 cells stably expressing TMX-myc were cultured in the absence (−) or presence (+) of tunicamycin (TM; 2 μg/ml) for 20 h. Cell lysates (lanes 1 and 2) and anti-myc immunoprecipitates (lanes 3 and 4) were analyzed by immunoblotting with anti-class I HC and anti-myc. Glycosylated (closed arrowhead) and nonglycosylated forms (open arrowhead) of class I HC are indicated. (B) A549 cells expressing TMX-myc were treated with or without tunicamycin as described in A. Cell lysates were first immunoprecipitated with anti-myc (1st IP), and the eluates were further immunoprecipitated with anti-calnexin (2nd IP). Coprecipitated class I HC was detected by immunoblotting (open arrowhead). *, coeluted antibody heavy chains (∼50 kDa). (C) 293 cells transfected with HLA-B27-V5 were incubated with (−) or without (+) MG-132 (10 μM) for 4 h and fractionated into cytosolic (C) and membrane (M) fractions. The translocation of MHC class I HC into the cytosol was examined by immunoblotting with anti-V5. The purity of each fraction was verified by immunoblots for ER marker calnexin. (D) 293 cells transfected with control vector (V) or HLA-B27-V5 (B27) were subjected to immunoprecipitation with anti-V5 and immunoblotted with anti-V5 and anti-TMX. Arrowhead denotes endogenous TMX coprecipitated with HLA-B27-V5. *, coeluted antibody light chains (∼25 kDa). (E) HLA-B27-V5 was cotransfected into 293 cells either with control vector (V) or with TMX-myc (TMX), and the translocation of HLA-B27 was analyzed as described in C. The gel was stained with Coomassie Blue (CBB) to ensure equal loading. Representative data are shown, and the band intensities of the cytosolic HLA-B27 are quantified. The Graph shows the mean ± SD of four experiments. (F) Control (Ctrl) and TMX knockdown cells (KD1 and KD2) were transfected with HLA-B27-V5, and the translocation of HLA-B27 was analyzed in the absence (−) or presence (+) of MG-132. Amido black staining of the same blot confirmed equal loading. Data are representative of two experiments and the intensities of HLA-B27 bands in the cytosol (lanes 4–6, open arrowhead) are quantified as shown in the graph.

Journal: Molecular Biology of the Cell

Article Title: Physical and Functional Interaction of Transmembrane Thioredoxin-related Protein with Major Histocompatibility Complex Class I Heavy Chain: Redox-based Protein Quality Control and Its Potential Relevance to Immune Responses

doi: 10.1091/mbc.E09-05-0439

Figure Lengend Snippet: Role of TMX in the degradation of MHC class I heavy chain. (A) A549 cells stably expressing TMX-myc were cultured in the absence (−) or presence (+) of tunicamycin (TM; 2 μg/ml) for 20 h. Cell lysates (lanes 1 and 2) and anti-myc immunoprecipitates (lanes 3 and 4) were analyzed by immunoblotting with anti-class I HC and anti-myc. Glycosylated (closed arrowhead) and nonglycosylated forms (open arrowhead) of class I HC are indicated. (B) A549 cells expressing TMX-myc were treated with or without tunicamycin as described in A. Cell lysates were first immunoprecipitated with anti-myc (1st IP), and the eluates were further immunoprecipitated with anti-calnexin (2nd IP). Coprecipitated class I HC was detected by immunoblotting (open arrowhead). *, coeluted antibody heavy chains (∼50 kDa). (C) 293 cells transfected with HLA-B27-V5 were incubated with (−) or without (+) MG-132 (10 μM) for 4 h and fractionated into cytosolic (C) and membrane (M) fractions. The translocation of MHC class I HC into the cytosol was examined by immunoblotting with anti-V5. The purity of each fraction was verified by immunoblots for ER marker calnexin. (D) 293 cells transfected with control vector (V) or HLA-B27-V5 (B27) were subjected to immunoprecipitation with anti-V5 and immunoblotted with anti-V5 and anti-TMX. Arrowhead denotes endogenous TMX coprecipitated with HLA-B27-V5. *, coeluted antibody light chains (∼25 kDa). (E) HLA-B27-V5 was cotransfected into 293 cells either with control vector (V) or with TMX-myc (TMX), and the translocation of HLA-B27 was analyzed as described in C. The gel was stained with Coomassie Blue (CBB) to ensure equal loading. Representative data are shown, and the band intensities of the cytosolic HLA-B27 are quantified. The Graph shows the mean ± SD of four experiments. (F) Control (Ctrl) and TMX knockdown cells (KD1 and KD2) were transfected with HLA-B27-V5, and the translocation of HLA-B27 was analyzed in the absence (−) or presence (+) of MG-132. Amido black staining of the same blot confirmed equal loading. Data are representative of two experiments and the intensities of HLA-B27 bands in the cytosol (lanes 4–6, open arrowhead) are quantified as shown in the graph.

Article Snippet: Rabbit polyclonal antibodies specific for calreticulin (SPA-600), calnexin (SPA-865), and PDI (SPA-890) were from Assay Designs (Ann Arbor, MI).

Techniques: Stable Transfection, Expressing, Cell Culture, Western Blot, Immunoprecipitation, Transfection, Incubation, Membrane, Translocation Assay, Marker, Control, Plasmid Preparation, Staining, Knockdown